May 27-28, 2009 Public Meeting on Risk Evaluation and Mitigation Strategies for Certain Opioids
On May 27-28, 2009, FDA held a public meeting on risk evaluation and mitigation strategies (REMS) and certain opioid drugs. During this meeting, more than 100 people provided comments on their experiences with opioid drugs along with suggestions for a REMS for long-acting and extended-release opioid products.
- Meeting Agenda (PDF - 81KB)
- Meeting Transcripts: